![]() |
市場調查報告書
商品編碼
1891547
角鯊烯市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032 年)Squalene Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032 |
||||||
全球角鯊烯市場正經歷強勁成長,這主要得益於化妝品、製藥和個人護理行業需求的成長,以及對永續植物性成分的轉向。 2024 年,全球角鯊烯市場價值為 1.696 億美元。預計到 2025 年,市場規模將成長至 1.8503 億美元,到 2032 年將達到 3.595 億美元,在整個預測期內保持強勁成長。 2024 年,歐洲在全球角鯊烯市場佔主導地位,市佔率高達 47.88%。這得歸功於先進的化妝品製造流程和以永續發展為導向的法規。
角鯊烯是一種天然存在的三萜烴 (C30H50)。角鯊烯傳統上提取自鯊魚肝油,但現在越來越多地從植物來源提取,例如橄欖油、小麥胚芽、甘蔗和莧菜籽。由於其優異的潤膚性能、輕盈的質地以及與人體皮膚的高親和力,角鯊烯被廣泛應用於護膚品、化妝品、藥品和功能性食品領域。
新冠疫情對市場的影響
新冠疫情對角鯊烯市場產生了複雜的影響。初期,經濟的不確定性和可支配支出的減少導致對高端保養品的需求下降。然而,隨著消費者居家時間增多,更加重視自我照護和健康,保養品的需求強勁反彈。
此外,製藥業在疫情期間成為主要的成長動力。角鯊烯被廣泛用作疫苗製劑中的佐劑,以增強免疫反應和疫苗效力。新冠疫苗的大規模生產顯著增加了製藥廠商對角鯊烯的需求,進一步鞏固了角鯊烯在全球醫療保健供應鏈中的戰略重要性。
市場趨勢
影響角鯊烯市場的關鍵趨勢包括對永續採購和植物基角鯊烯日益增長的需求。消費者和品牌對環境永續性、海洋保護和動物福利的日益關注,正促使他們逐步淘汰鯊魚來源的成分。
源自橄欖、甘蔗和莧菜籽的植物基角鯊烯,提供了不經動物實驗且環保的替代方案。化妝品和個人護理品牌越來越致力於符合道德規範的採購和永續發展目標,這使得植物基角鯊烯成為更受歡迎的成分。監管審查的加強和消費者對成分來源透明度的需求,進一步推動了這一轉變。
市場成長驅動因素
化妝品和護膚品產業仍然是角鯊烯市場成長的關鍵推動力。角鯊烯因其深層保濕、提升肌膚彈性和修復肌膚屏障且不留黏膩殘留的特性而備受推崇。隨著消費者越來越注重護膚,對高效天然成分的需求也正在加速成長。
該產品符合清潔美容和天然配方趨勢,進一步促進了其市場普及。此外,其抗衰老特性使其成為高端護膚品、精華液、保濕霜和抗皺配方中備受青睞的成分。
另一個關鍵驅動因素是角鯊烯作為疫苗佐劑在醫藥領域的應用日益廣泛。角鯊烯佐劑能夠增強免疫反應,進而提高疫苗的有效性。其在新冠疫苗配方中的應用顯著提升了市場需求。對其免疫調節特性和先進藥物遞送系統的持續研究預計將在整個預測期內維持醫藥領域的需求。
市場限制因子
儘管成長前景強勁,但由於與鯊魚來源角鯊烯相關的環境和倫理問題,市場面臨諸多限制因素。過度捕撈鯊魚以提取肝油引發了人們對生物多樣性和海洋生態系統的嚴重擔憂。這些問題導致監管審查加大,消費者抵制情緒高漲,限制了動物來源角鯊烯在多個地區的接受度。
依原料劃分,截至2024年,動物來源細分市場佔主導地位。這主要是由於鯊魚來源角鯊烯在化妝品和醫藥領域長期使用。然而,由於永續發展倡議和符合倫理的採購要求,植物來源細分市場預計將呈現最高的成長率。
依終端用戶產業劃分,化妝品產業在2024年佔最大的市場佔有率,這主要得益於其在護膚品中的廣泛應用。製藥業也佔了相當大的佔有率,這主要歸功於疫苗的研發和免疫計畫的擴展。
2024年,歐洲在全球角鯊烯市場中佔領先地位,市場規模達8,120萬美元。該地區受益於強大的化妝品製造能力、消費者對清潔標籤產品的高需求以及對永續採購實踐的早期採用。
北美地區保養品市場需求強勁。同時,由於製藥業的擴張和疫苗產量的增加,亞太地區預計將快速成長。拉丁美洲擁有豐富的植物原料,因此在採購方面具有優勢,而中東和非洲地區對永續化妝品原料的需求也不斷增長。
The global squalene market is witnessing strong expansion, driven by increasing demand from the cosmetics, pharmaceutical, and personal care industries, alongside a growing shift toward sustainable and plant-based ingredients. In 2024, the global squalene market size was valued at USD 169.6 million. The market is projected to grow to USD 185.03 million in 2025 and further reach USD 359.5 million by 2032, reflecting robust growth over the forecast period. Europe dominated the global squalene market in 2024, accounting for a 47.88% market share, supported by advanced cosmetic manufacturing and sustainability-focused regulations.
Squalene is a naturally occurring triterpene hydrocarbon (C30H50), traditionally sourced from shark liver oil and increasingly derived from plant-based alternatives such as olive oil, wheat germ, sugarcane, and amaranth seed. Due to its excellent emollient properties, lightweight texture, and high compatibility with human skin, squalene is widely used in skincare, cosmetics, pharmaceuticals, and functional food applications.
Impact of COVID-19 on the Market
The COVID-19 pandemic had a mixed impact on the squalene market. During the initial phase, demand for luxury skincare products declined due to economic uncertainty and reduced discretionary spending. However, as consumers spent more time at home and prioritized self-care and wellness, demand for skincare products rebounded strongly.
Additionally, the pharmaceutical industry emerged as a key growth contributor during the pandemic. Squalene is widely used as an adjuvant in vaccine formulations, enhancing immune response and vaccine effectiveness. The mass production of COVID-19 vaccines led to a notable surge in demand from pharmaceutical manufacturers, reinforcing the strategic importance of squalene in global healthcare supply chains.
Market Trends
A key trend shaping the squalene market is the rising demand for sustainably sourced and plant-based squalene. Growing awareness around environmental sustainability, marine conservation, and animal welfare has led consumers and brands to move away from shark-derived sources.
Plant-based squalene sourced from olives, sugarcane, and amaranth seed offers a cruelty-free and environmentally responsible alternative. Cosmetic and personal care brands are increasingly committing to ethical sourcing and sustainability goals, making plant-derived squalene a preferred ingredient. This shift is further supported by regulatory scrutiny and consumer demand for transparency in ingredient sourcing.
Market Growth Drivers
The cosmetics and skincare industry remains the primary growth driver for the squalene market. Squalene is valued for its ability to deeply moisturize, improve skin elasticity, and restore the skin barrier without leaving a greasy residue. As consumer focus on skincare routines continues to grow, demand for high-performance, naturally derived ingredients is accelerating.
The product's alignment with clean beauty and natural formulation trends further strengthens its adoption. In addition, its anti-aging properties make it a highly desirable ingredient in premium skincare products, serums, moisturizers, and anti-wrinkle formulations.
Another major driver is the growing pharmaceutical application of squalene as a vaccine adjuvant. Squalene-based adjuvants enhance immune response, enabling improved vaccine efficacy. Their use in COVID-19 vaccine formulations significantly boosted market demand. Ongoing research into immunomodulatory properties and advanced drug delivery systems is expected to sustain pharmaceutical sector demand over the forecast period.
Market Restraints
Despite strong growth prospects, the market faces restraints related to environmental and ethical concerns associated with shark-derived squalene. Overexploitation of sharks for liver oil extraction has raised serious biodiversity and marine ecosystem concerns. These issues have led to increased regulatory scrutiny and consumer backlash, limiting acceptance of animal-derived squalene in several regions.
By source, the animal segment dominated the market in 2024, owing to the long-standing use of shark-derived squalene in cosmetics and pharmaceuticals. However, the plant segment is expected to grow at the fastest rate, driven by sustainability initiatives and ethical sourcing requirements.
By end-use industry, the cosmetics segment held the largest market share in 2024, supported by widespread adoption in skincare formulations. The pharmaceutical segment also accounted for a significant share due to vaccine development and expanding immunization programs.
Europe led the global squalene market in 2024, with a market size of USD 81.2 million. The region benefits from strong cosmetic manufacturing capabilities, high consumer demand for clean-label products, and early adoption of sustainable sourcing practices.
North America shows strong demand from the skincare sector, while Asia Pacific is expected to witness rapid growth due to pharmaceutical expansion and increasing vaccine production. Latin America offers sourcing advantages due to abundant plant-based raw materials, while the Middle East & Africa is experiencing growing demand for sustainable cosmetic ingredients.
Competitive Landscape
Key players in the squalene market are focusing on product development, sustainable sourcing, and capacity expansion to strengthen their market presence. Companies are increasingly investing in plant-based and biosynthetic alternatives to address ethical concerns and meet evolving consumer expectations.
With rising demand from skincare, pharmaceuticals, and sustainability-driven industries, the global squalene market is positioned for strong growth through 2032.
Segmentation By Source
By End-Use Industry
By Region